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Abstract;  
Background; The magnitude of damage caused by these microvascular complications of diabetes stresses the 
need for sensitive markers of screening for retinopathy and nephropathy. This study was done to determine the 
frequency of microalbuminuria in patients with diabetic retinopathy. Material and methods; A total of 300 
patients’ type 2 diabetic patients with diabetic retinopathy presenting in Diabetes OPD of Nishtar Hospital, 
Multan were selected. After taking informed written consent, all patients underwent retinal imaging using Non 
Mydriatic Fundus Camera (NIDEK® Model # AFC-330). Urine sample of each patient was sent to the institute 
pathology laboratory for measuring albumin / creatinine ratio. Grades of retinopathy and microalbuminuria. 
Collected Data was entered into SPSS version 17.0 and was analyzed through its statistical package. Results; 
 Of these 300 study cases, 179 (59.7%) were male patients while 121 (40.3%) were female patients. 
Mean age of our study cases was 52.10 ± 5.65 years (with minimum age was 42 years while maximum age was 
60 years).  Most of our study cases were from poor socioeconomic background i.e. 170 (56.7%) while 
only 13.3 % belonged to the higher socio-economic status. Majority of our study cases were having low 
educational level such as illiterate i.e. 60 (20%), primary education in 71 (23.7%) while only 3 % had bachelors 
degree or above. Mean duration of diabetes was 14.18 ± 2.73 years (with minimum duration of disease was 10 
years while 19 years was maximum duration of the disease). Among these patients Grade III diabetic 
retinopathy was more prevalent i.e. 149 (49.7%) followed by grade IV retinopathy i.e. 100 (33.3%). Diabetes 
was controlled in only 81 (27%) of our study cases and obesity was present in 101 (33.7%) of our study cases. 
Microalbuminuria was present in 121 (40.3%) of our study cases. 
Conclusion; Very high frequencies of microalbuminuria were noted in patients with diabetic retinopathy in our 
study. Microalbuminuria was significantly associated with female gender, increasing age, socio-economic 
status, low educational level, disease severity, disease duration and obesity. Microalbuminuria was not 
associated with control of diabetes.  
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Introduction: 
 Diabetes is a group of metabolic diseases characterized by hyperglycemia resulting from defects in 
insulin secretion, insulin action, or both. The chronic hyperglycemia of diabetes is associated with long-term 
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damage, dysfunction, and failure of different organs, especially eyes; kidneys, nerves, heart, and blood 
vessels.
1
There are three main types of diabetes mellitus (DM): Type I, Type II and gestational diabetes.
2 
 The multisystem complications of diabetes such as retinopathy, nephropathy, neuropathy and 
cardiovascular diseases are considered important, impinging on public health.
3
 Diabetic nephropathy (DN) and 
diabetic retinopathy (DR) are arguably the two most dreaded complications of diabetes. Together they 
contribute to serious morbidity and mortality. As they progress to end-stage renal disease (ESRD) and blindness, 
they impose enormous medical, economic, and social costs on both the patient and the health care system. 
Because nephropathy and retinopathy are frequently linked in patients.4 
 
Both ESRD and blindness are preventable through early detection and treatment.The concordance of 
microalbuminuria and diabetic retinopathy has been well reported in persons with type 1 diabetes.
5, 6
 However 
for type 2 diabetes, there is paucity of data especially from population-based studies regarding the association of 
microalbuminuria with diabetic retinopathy.7-12 In a study done by Manaviat MR et al8, positive correlation was 
seen between microalbiminuria and diabetic retinopathy and 25.9% patients of diabetic retinopathy had shown 
microalbuminuria.   
 
Materials and methods: 
A total of 300 patients’ type 2 diabetic patients with diabetic retinopathy aged 40 to 60 years, having diabetic 
retinopathy grade II and above and duration of diabetes for more than 10 years presenting in Diabetes OPD were 
selected. Patients underwent any form of retinal surgery / laser therapy, patients on ACE-inhibitors or ARBs, 
patients have any other Kidney disease, cataract, patient having Hypertensive retinopathy were excluded from 
our study.  
After taking informed written consent, all patients underwent retinal imaging using Non Mydriatic Fundus 
Camera (NIDEK® Model # AFC-330). Urine sample of each patient was sent to the institute pathology 
laboratory for measuring albumin / creatinine ratio. Grades of retinopathy and microalbuminuria. Collected Data 
was entered into SPSS version 17.0 and was analyzed through its statistical package.  
 
Results; 
 Our study comprised of 300 patients having diabetic retinopathy meeting inclusion and exclusion 
criteria of our study. Of these 300 study cases, 179 (59.7%) were male patients while 121 (40.3%) were female 
patients. Mean age of our study cases was 52.10 ± 5.65 years (with minimum age was 42 years while maximum 
age was 60 years). Mean age of the male patients was 52.07 ± 5.49 years while that of female patients was 52.15 
± 5.89 years (p=0.902). Our study results have indicated that majority of our study cases i.e. 180 (605) belonged 
to age group of 51 – 60 years of age. Most of our study cases were from poor socioeconomic background i.e. 
170 (56.7%) while only 13.3 % belonged to the higher socio-economic status. Majority of our study cases were 
having low educational level such as illiterate i.e. 60 (20%), primary education in 71 (23.7%) while only 3 % 
had bachelors degree or above. Mean duration of diabetes was 14.18 ± 2.73 years (with minimum duration of 
disease was 10 years while 19 years was maximum duration of the disease). Our study results have indicated 
that majority of our study cases i.e. 171 (57%) had disease duration ranging from 10 to 15 years. Among these 
patients Grade III diabetic retinopathy was more prevalent i.e. 149 (49.7%) followed by grade IV retinopathy 
i.e. 100 (33.3%).  Diabetes was controlled in only 81 (27%) of our study cases and obesity was present in 101 
(33.7%) of our study cases. Microalbuminuria was present in 121 (40.3%) of our study cases and 
microalbuminuria was stratified with regards to gender, age, socioeconomic status, educational status, disease 
duration, grades of retinopathy, control of diabetes and obesity and p values were found to be p= 0.004, 
p=0.054, p=0.000, p=0.000, p=0.000, p=0.000, p= 0.063 and p = 0.025 respectively.  
 
Discussion;  
As the number of persons with diabetes increases, the development of microvascular complications like 
retinopathy, nephropathy and neuropathy also rises. These microvascular complications are linked to the 
duration of diabetes mellitus, poor glycemic control and systolic hypertension. The magnitude of damage caused 
by these microvascular complications of diabetes stresses the need for sensitive markers of screening for 
retinopathy and nephropathy 13-15 
Our study comprised of 300 patients having diabetic retinopathy, out of these 300 study cases, 179 (59.7%) 
were male patients while 121 (40.3%) were female patients. A study conducted in India by Thakkar et al 
16
 
reported 57 % male patients with diabetes screened for microalbuminuria, these findings are similar to that of 
our study results. Saleem et al 17 reported male gender predominance over female patients i.e. 54.14 % male 
Journal of Medicine, Physiology and Biophysics                                                                                                                              www.iiste.org 
ISSN 2422-8427     An International Peer-reviewed Journal 
Vol.40, 2018 
 
42 
patients, these findings are similar to that of our study results. Rani et al 
13
 reported 52.2 % male patients which 
is same as that of our study results.  
 
Different studies have reported that frequency of diabetic retinopathy is more in patients with increasing age. 
Mean age of our study cases was 52.10 ± 5.65 years (with minimum age was 42 years while maximum age was 
60 years). Rani et al 
13
 reported 58.6 ± 9.6 mean age of diabetic patients with retinopathy, these findings are 
close to that of our study results. Nisar et al 18 reported 52.18 ± 8.99 years which is similar to that of our study 
results. Jamil et al 19 reported 50.95 ± 10.12 years mean age for the newly diagnosed diabetic patients screened 
for retinopathy, these findings are also in compliance with that of ours. Thakkar et al 
16
 61.91 ± 9.16 which is 
quite higher than our study results, the reason for this disparity is that we only included patients ranging from 
40-60 years of age.  
 
Mean age of the male patients was 52.07 ± 5.49 years while that of female patients was 52.15 ± 5.89 years. Our 
study results have indicated that majority of our study cases i.e. 180 (605) belonged to age group of 51 – 60 
years of age. Similar results have been reported by Jamil et al91. Similar results have by reported by Nisar et al19.  
 
Most of our study cases were from poor socioeconomic background i.e. 170 (56.7%) while only 13.3 % 
belonged to the higher socio-economic status. Majority of our study cases were having low educational level 
such as illiterate i.e. 60 (20%), primary education in 71 (23.7%) while only 3 % had bachelors degree or above.  
 
Mean duration of diabetes was 14.18 ± 2.73 years (with minimum duration of disease was 10 years while 19 
years was maximum duration of the disease). Our study results have indicated that majority of our study cases 
i.e. 171 (57%) had disease duration ranging from 10 to 15 years. Crimi et al 20 reported 14.7 ± 7.1 years mean 
duration of diabetes in diabetic retinopathy, these results are close to that of our study results. Rani et al 13 6.6 
years mean disease duration among targeted population. These fidnigs are quite lower than that of our study 
results which can be demonstrated in terms that our inclusion criteria only registered patients with duration of 
diabetes equal or more than 10 years. Among these patients Grade III diabetic retinopathy was more prevalent 
i.e. 149 (49.7%) followed by grade IV retinopathy i.e. 100 (33.3%). Diabetes was controlled in only 81 (27%) of 
our study cases and obesity was present in 101 (33.7%) of our study cases. Similar results have by reported  by 
Rani et al 
13
 and Thakkar et al 
16
.  
 
Microalbuminuria was present in 121 (40.3%) of our study cases. Nisar et al 
18
 from Lahore reported 45.4 % 
frequency of microalbuminuria in patients with diabetic retinopathy, these findings are close to our study results. 
Crimi et al 
20
 reported 23 % micoalbuminuria in diabetic retinopathy. Manaviat et al
8
 reported 25.9% frequency 
of microalbuminuria in patients with diabetic retinopathy. Thakkar et al 16 reported as high as 100 % 
microalbuminuria in patients with diabetic retinopathy which is very high than our study results.  
 
Conclusion; 
Very high frequencies of microalbuminuria were noted in patients with diabetic retinopathy in our study. 
Microalbuminuria was significantly associated with female gender, increasing age, socio-economic status, low 
educational level, disease severity, disease duration and obesity. Microalbuminuria was not associated with 
control of diabetes.  
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